Pharmaceutical Network February 6 hearing With the gradual promotion of the strategy of "Healthy China" and the extensive social demand for medical services, the life and health industry ushered in the investment and development of the outlet. Many investors and entrepreneurs fought in succession and joined the wave of industry.
As the earlier focus on domestic medical instruments Every year, we are exposed to hundreds of medical projects, and it is hard to start a business. It is even more difficult to start a business in the medical circle. Regardless of the seriousness of product research and development, Not to mention there are complex channel construction.
Here, on the point of investment in the medical industry entrepreneurship, I talk about some personal experience, we welcome correction.
First of all, I would like to express my respect for the entrepreneurs.It is not easy to start a business, to challenge the body and mind, to have enough courage to take the path of starting a business, no matter what happens, courage.
Courage, but also need to be rational.Enterprise is a dynamic process of development, all stages of its own focus.Early focus on products, mid-term selection financing, there are always strategic choices.
First, the product selection
Entrepreneurs with different biographies are suitable for different product choices, and most of the entrepreneurs who are research and development start-up will have innovative technologies, and the products will naturally be technology-driven. The originators of sales naturally want to maximize the channel benefits they have.
Taking high-end medical equipment as an example, it involves multidisciplinary crossings and is a typical patent jungle. The clinical requirements are strict and the registration process is rigorous. The products have a long period of going out of the lab to the market for sale. Although there are not many market competitors, the access threshold Excessive, suitable for a team of entrepreneurs and long-term investors who have a certain research and development strength and financial reserves.
In comparison, high value supplies technical threshold is not high, the development cycle is relatively short, won a customer, the follow-up will continue to buy, the high value of customer maintenance, more suitable for general entrepreneurs and short-term investors on the return on financial needs. Indiscriminate use of words, the output benefit of medical device products is 'big and small, hard as soft'.
Second, financing options
enterprise Development to a certain stage, is bound to encounter capital bottlenecks.At this point, whether to choose to dilute the shares into the strategic investment? Entrepreneurs believe that the capital intervention will lead to the loss of business autonomy, I believe that in the current economic environment, enterprises must have an open and win-win Thinking, to accept the help of capital, in order to achieve rapid development of enterprises.
Instead of guarding the tens of millions of plates stand still, it is better to release part of the equity will be the overall size bigger, get the industry the right to speak before they can be stronger.
How to choose that investors? Currently a lot of hot money on the market, many of them from the transformation of traditional industries, investors, their life health Very optimistic about the industry, the project is generally not tangled, money is very cool.
However, because of the particularity of the medical industry and the long business cycle, such investors can not understand that the products can not be marketed for five years and eight years. The capital-chasing characteristics will restrict the development of enterprises everywhere and will not be able to talk about the help of funds.
The industrial capital is not the same, because of its own built a mature industry platform, once docked, in addition to capital injection, but also give a variety of industrial resources venture project, help enterprises quickly embarked on the fast lane of growth and development. Therefore, even if Valuation is low, I still recommend choosing a professional investment agency.
Third, the strategic choice
Most entrepreneurs have the dream of IPO, but the big data shows mercilessly that the probability of realization of this dream is close to one in ten. Compared with the traditional industries, the medical industry has a high technical threshold, a single product line, market segmentation and more The face of ordinary consumers, volume is difficult to enlarge the other hand, timing is right or not is the key.
then heart Stents are monopolized by foreign brands at high prices, the market urgently needs the appearance of domestic brands, and Lepu Medical is in its prime.Mei Kang Bio has grasped the opportunity for the vigorous development of IVD industry and Huada Gene is also the easiest way to take advantage of Precise Medical.
Therefore, I think Entrepreneurship In the process of development, if we can get the reward of Bole, be merged or controlled by a listed company or a leading enterprise and develop in a mature ecosystem, it is a very good way to serve the public as soon as possible.
